Altaris Capital Partners

Altaris Capital Partners is a private equity firm based in New York City, focusing exclusively on the healthcare sector. Since its inception in 2003, the firm has invested in over 50 companies across various healthcare subsectors, aiming to deliver value to the healthcare system and generate attractive financial returns for investors. As of June 2024, Altaris manages more than $9 billion in equity capital.

The firm's investment strategy involves acquiring and building companies with proven business models, targeting growth-oriented buyouts and complex, value-based situations. Altaris seeks to be a partner of choice for the healthcare industry by providing strategic solutions rather than merely transactional capital. Their approach includes active ownership and board membership to drive sustainable growth and long-term shareholder value appreciation.

Altaris has a track record of doubling revenue and profitability on average for its portfolio companies. The firm's portfolio includes active operating companies, with a consistent goal of improving access and outcomes for patients. Notable investments include Minnetronix, a medical technology company, and partnerships with global corporations and healthcare systems such as 3M, Michelin, Providence, GE, and Pfizer. The firm's leadership comprises co-founders George Aitken-Davies and Daniel Tully, along with managing directors like Aaron Bell and Lana Dweik.